Clinical Trials
All Clinical Trials - Page 22 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05779644N/AUnknown
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
Semaglutide
- NCT05622123Phase 2Unknown
BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
Exenatide
- NCT05755360N/ACompleted
DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy
Semaglutide
- NCT05813249Phase 4Completed
Semaglutide in Nonalcoholic Fatty Liver Disease
Semaglutide
- NCT05607004Phase 2Active Not Recruiting
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Ghrp-6
- NCT05536804Phase 2Completed
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Tirzepatide
- NCT05696847Phase 1Completed
A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
Tirzepatide
- NCT05691712Phase 3Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Tirzepatide
- NCT05896293Phase 2Recruiting
Kisspeptin Administration Subcutaneously to Patients With IHH
Kisspeptin
- NCT05982093Phase 2Recruiting
Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
Gonadorelin
- NCT05419726N/ARecruiting
Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
Semaglutide
- NCT05622045N/AActive Not Recruiting
Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)
Semaglutide
- NCT05394519Phase 3Completed
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
Semaglutide
- NCT05610124N/AUnknown
Postprandial Glycemia and Satiety of Meals With Potatoes, With and Without Protein
Ghrp-6
- NCT07340437N/ACompleted
Clinical Study of 18F-Exendin-4 in Insulinoma
Exenatide
- NCT05605964Phase 3Completed
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
Gonadorelin
- NCT06607666N/ACompleted
Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands
Lanreotide
- NCT05669599Phase 2Completed
Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
Maridebart-Cafraglutide
- NCT05720260Phase 2Recruiting
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Gonadorelin
- NCT05705388N/AUnknown
POSE2.0 With GLP-1 Agonist for Obesity Management
Liraglutide
- NCT04915144Phase 2Withdrawn
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
Octreotide
- NCT05700877Phase 4Recruiting
Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
Semaglutide
- NCT05680129Phase 3Completed
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
Dulaglutide
- NCT05606913Phase 3Completed
A Study of IBI362 in Participants With Type 2 Diabetes
Dulaglutide
- NCT05628311Phase 3Completed
A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Mazdutide
- NCT05597202Phase 4Unknown
Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
Semaglutide
- NCT07674290Phase 4Recruiting
Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity
Setmelanotide
- NCT05659537Phase 4Completed
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
Dulaglutide
- NCT05652205Phase 3Completed
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation
Linaclotide
- NCT05709444Phase 2Completed
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
PT-141
- NCT05638594Phase 2Recruiting
Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer
Gonadorelin
- NCT05749289Phase 2/Phase 3Recruiting
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
Octreotide
- NCT06201819Phase 4Completed
Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
Liraglutide
- NCT05633966Phase 1Completed
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
Kisspeptin
- NCT04589819Phase 4Enrolling By Invitation
Fracture Recovery for Returning to Duty (Teriparatide STRONG)
Teriparatide
- NCT05610800Phase 2Completed
Exenatide for Smoking Cessation and Prevention of Weight Gain
Exenatide
- NCT05767255Phase 3Unknown
Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue
Liraglutide
- NCT06185361N/AUnknown
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
Desmopressin
- NCT05564039Phase 4Completed
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
Tirzepatide
- NCT05768945N/ACompleted
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Semaglutide
- NCT05107219Phase 1Completed
GCC Agonist Signal in the Small Intestine
Linaclotide
- NCT06217848EARLY_Phase 1Unknown
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Liraglutide
- NCT05598008N/ACompleted
Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
Liraglutide
- NCT05617664N/AUnknown
Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis
Desmopressin
- NCT05347147Phase 3Terminated
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Exenatide
- NCT05590793Phase 3Completed
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
Gonadorelin
- NCT05611957Phase 1Completed
A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
Retatrutide
- NCT05616013Phase 2Completed
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
Semaglutide
- NCT05623839Phase 1Completed
A Study of LY3305677 in Participants With Obesity Or Overweight
Mazdutide
- NCT05607680Phase 3Completed
A Study of IBI362 in Participants With Obesity or Overweight
Mazdutide